At the end of July, the Shenzhen Stock Exchange released an announcement on the results of the 7^th review meeting of the GEM Listing Committee. Zhejiang Weikang Pharmaceutical (Wecome Pharma) passed the meeting successfully. According to the prospectus, the offering will raise RMB 540 million yuan (USD $77.4 million), of which RMB 359 million yuan (USD $51.5) will be used for the first phase of the pharmaceutical health industrial park project construction.

The project covers an area of about 200 acres, with a total construction area of nearly 200,000 square meters, with 9 construction projects planned to be built, including a pharmaceutical quality inspection building, an intelligent Chinese medicine extraction building, a modern Chinese medicine beverage factory, a modern pharmaceutical logistics center, a national key laboratory and a research and development center. (Source: Eastmoney Finance)

Comments are closed.